Why women need different telehealth solutions

Most telehealth platforms were built with a gender-neutral approach that, in practice, works better for men. Weight gain, metabolism, and response to GLP-1 medications are all significantly influenced by hormonal factors that are unique to women — and that change dramatically through perimenopause and menopause.

Estrogen decline shifts fat storage from hips and thighs to the abdomen. Insulin resistance increases. Thyroid dysfunction becomes more common. Cortisol regulation changes. Sleep disruption compounds everything. A platform that treats a 47-year-old perimenopausal woman the same as a 35-year-old man is leaving most of the clinical picture unaddressed.

The platforms below are the ones that actually understand this.

The most important decision for women: Whether to start with hormone optimization (FemExcel) or GLP-1 therapy (DirectMeds) — or both simultaneously. This depends heavily on your hormonal status and primary symptoms. Women in perimenopause or menopause with significant hormonal symptoms often benefit from addressing hormones first or alongside GLP-1 therapy.

The best telehealth platforms for women in 2026

1 FemExcel — Best for hormones + weight
Hormone-first women's health telehealth — from ~$79/mo — most U.S. states
★★★★☆

FemExcel is the platform we recommend first for women whose weight struggles have a hormonal component — which is most women over 35 and virtually all women in perimenopause or menopause. Their intake process evaluates estrogen, progesterone, thyroid, cortisol, testosterone, and insulin — the full hormonal picture that drives metabolic and weight changes in women.

Most telehealth platforms that offer GLP-1 medications treat hormonal status as irrelevant. FemExcel treats it as the foundation. For women who have done everything right — tracked calories, exercised consistently, tried multiple programs — and still struggled to lose weight, a comprehensive hormonal evaluation frequently reveals why.

What we liked

  • Comprehensive hormonal evaluation
  • Women-only clinical team
  • Addresses thyroid, estrogen, progesterone, testosterone
  • Personalized treatment plans
  • Starting at ~$79/mo

Worth knowing

  • Not primarily a GLP-1 platform
  • Hormone therapy carries risks — discuss with provider
  • Not available in all states
Start your FemExcel evaluation → Women only  ·  Licensed clinician consultation  ·  Most U.S. states
2 DirectMeds — Best GLP-1 access for women
Compounded semaglutide & tirzepatide from ~$99/mo — all 50 states
★★★★★

For women whose primary goal is GLP-1 weight loss therapy — whether hormones are a secondary concern or not — DirectMeds is the most accessible and affordable option. Compounded semaglutide and tirzepatide with real physician oversight, transparent pricing from $99/month, available nationwide.

GLP-1 medications work well in women, though the hormonal factors we describe above can affect response. Women in perimenopause with significant insulin resistance may find tirzepatide (which has a stronger metabolic effect through its GIP component) works better than semaglutide. Discuss this with your DirectMeds provider during intake.

What we liked

  • Lowest starting price (~$99/mo)
  • Both semaglutide and tirzepatide
  • Physician consultation included
  • Available in all 50 states
  • Ongoing monitoring

Worth knowing

  • Not gender-specific — general GLP-1 platform
  • Doesn't address hormonal factors
  • Best paired with hormone evaluation for perimenopausal women
Check eligibility at DirectMeds → Free eligibility check  ·  All 50 states  ·  Physician review required
3 AgelessRx — Best for longevity optimization
NAD+ therapy and metabolic optimization — from ~$99/mo — all 50 states
★★★★☆

For women who have addressed foundational health and want to optimize cellular energy, cognitive function, and long-term metabolic health, AgelessRx offers the most credible and accessible longevity telehealth available. NAD+ decline accelerates through menopause — women in their 40s and 50s are often the patients who notice the most significant benefits from NAD+ injection therapy.

What we liked

  • NAD+ injections at home
  • Energy and cognitive clarity benefits
  • Provider supervision included
  • Ships all 50 states
  • Much more affordable than IV clinics

Worth knowing

  • Not a weight loss platform
  • Self-injection required
  • Best as complement to other treatments
Explore AgelessRx programs →

Choosing the right platform for your situation

Perimenopause weight gain

Hormonal shifts are likely driving the problem. Hormone evaluation first.

→ FemExcel

GLP-1 weight loss, no hormonal concerns

Direct GLP-1 access at the lowest cost.

→ DirectMeds

Both hormones + GLP-1

The most comprehensive approach — can be used simultaneously.

→ FemExcel + DirectMeds

PCOS-related weight gain

Insulin resistance is the primary driver. Tirzepatide via DirectMeds.

→ DirectMeds (tirzepatide)

Energy + cognitive decline

NAD+ decline is common in women 40+.

→ AgelessRx

Comprehensive optimization

All three approaches address different layers of the same problem.

→ FemExcel + DirectMeds + AgelessRx

Not sure where to start?

For most women, the highest-impact starting point is either hormonal evaluation (FemExcel) or GLP-1 access (DirectMeds) depending on your primary concern. Both offer free consultations.

Start your FemExcel evaluation →

Frequently asked questions

Should I try hormones or GLP-1 first for weight loss?
It depends on your hormonal status. If you're in perimenopause or menopause and have significant hormonal symptoms (hot flashes, sleep disruption, mood changes, significant abdominal weight gain), starting with or including hormone evaluation makes clinical sense — the hormonal changes may be the primary driver of your weight gain. If you're younger or have no significant hormonal symptoms, GLP-1 therapy is the more direct starting point. Many women benefit from both simultaneously.
Does semaglutide work differently in women than men?
The mechanism is the same but hormonal factors affect response. Women report higher rates of GI side effects than men. Perimenopausal and menopausal women with insulin resistance may respond better to tirzepatide's dual mechanism than semaglutide's single mechanism. Women who address hormonal factors alongside GLP-1 therapy tend to see better outcomes than those who use GLP-1 alone when hormonal issues are present.
Can I use FemExcel and DirectMeds at the same time?
Yes — many women use both. Hormone therapy and GLP-1 medications address different biological mechanisms and are not contraindicated together. Always disclose all treatments to both providers so they have your complete clinical picture. Some providers specifically recommend combining hormone optimization with GLP-1 therapy for perimenopausal patients as the most comprehensive approach.
Is telehealth safe for women's hormone therapy?
Hormone therapy carries real risks that vary significantly by individual — blood clot risk, cardiovascular effects, and certain cancer risks depend on your personal and family medical history. The quality of the clinical evaluation before prescribing is what separates safe telehealth hormone therapy from dangerous prescribing. FemExcel conducts thorough intake evaluations specifically to assess these individual risks — this is not a platform that issues prescriptions without understanding your full health picture.